These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6894778

  • 1. Surfactant 1981.
    Gupta JM.
    Med J Aust; 1981 May 30; 1(11):557-8. PubMed ID: 6894778
    [No Abstract] [Full Text] [Related]

  • 2. Review of experimental hyaline membrane disease.
    Robertson B.
    Diagn Histopathol; 1981 May 30; 4(1):49-60. PubMed ID: 7018865
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May 30; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Surfactant replacement therapy.
    Kresch MJ, Lin WH, Thrall RS.
    Thorax; 1996 Nov 30; 51(11):1137-54. PubMed ID: 8958900
    [No Abstract] [Full Text] [Related]

  • 7. Physiological effects of reduction in lung surfactant.
    Reynolds EO.
    Proc R Soc Med; 1973 Apr 30; 66(4):388-9. PubMed ID: 4740402
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Exogenous surfactants in neonatology].
    Zupan V, Meric M, Dehan M.
    Rev Mal Respir; 1995 Apr 30; 12(6):642-5. PubMed ID: 8677364
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Surfactant treatment in experimental hyaline membrane disease.
    Nilsson R, Grossmann G, Berggren P, Robertson B.
    Eur J Respir Dis; 1981 Dec 30; 62(6):441-9. PubMed ID: 6922790
    [Abstract] [Full Text] [Related]

  • 14. What is new in our understanding of perinatal pulmonary problems? Presidential address to the Society for Pediatric Research, May 19, 1973.
    Avery ME.
    Pediatr Res; 1973 Oct 30; 7(10):842-5. PubMed ID: 4583722
    [No Abstract] [Full Text] [Related]

  • 15. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA, Hutchins GM.
    Am J Perinatol; 1998 Oct 30; 15(9):539-44. PubMed ID: 9890252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
    Storme L, Truffert P, Rakza T, Lequien P.
    Arch Pediatr; 1999 May 30; 6(5):549-55. PubMed ID: 10370813
    [Abstract] [Full Text] [Related]

  • 18. Hyaline membrane disease: future treatment modalities.
    Richardson C.
    J Perinat Neonatal Nurs; 1988 Jul 30; 2(1):78-88. PubMed ID: 3379615
    [No Abstract] [Full Text] [Related]

  • 19. [Deficiency of surfactant in the newborn: pulmonary hyaline membrane disease].
    Salvioli GP.
    Torace; 1976 Jan 30; 18(1-2):3-12. PubMed ID: 1036633
    [No Abstract] [Full Text] [Related]

  • 20. The pulmonary surfactant.
    Sekabunga JG.
    East Afr Med J; 1973 Jan 30; 50(1):27-32. PubMed ID: 4578486
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.